Articles published by Melanoma Research Alliance

Melanoma Research Alliance Appoints Stephanie Kauffman as Chief Executive Officer

June 04, 2026

From Melanoma Research Alliance

Via GlobeNewswire

Leveraged Finance & Private Equity Communities Unite to Raise Record $3 Million for Melanoma Research

June 17, 2022

From Melanoma Research Alliance

Via Business Wire

Melanoma Research Alliance Announces $13 Million in Grants to Advance Melanoma Prevention, Detection & Treatment

May 19, 2022

From Melanoma Research Alliance

Via Business Wire

The Melanoma Research Alliance Names Dr. Marc Hurlbert as Chief Executive Officer

May 12, 2022

From Melanoma Research Alliance

Via Business Wire

Melanoma Research Alliance Statement on FDA Approval of Relatlimab + Nivolumab for Treatment of Advanced Melanoma

March 18, 2022

From Melanoma Research Alliance

Via Business Wire

Melanoma Research Alliance Statement on FDA Approval of Tebentafusp, the First Drug for Treating Metastatic Uveal Melanoma

January 26, 2022

From Melanoma Research Alliance

Via Business Wire

Melanoma Research Alliance Applauds Expanded Approval of Pembrolizumab to Patients with Stage 2 Disease

December 06, 2021

From Melanoma Research Alliance

Via Business Wire

Leveraged Finance & Private Equity Communities Come Together to Raise $2.4 Million at 10th Annual Leveraged Finance Fights Melanoma Event

October 04, 2021

From Melanoma Research Alliance

Via Business Wire

Melanoma Research Alliance Announces 13 Dermatology Fellowship Award Recipients

July 08, 2021

From Melanoma Research Alliance

Via Business Wire

Melanoma Research Alliance Announces $8.1 million in Research Awards

April 27, 2021

From Melanoma Research Alliance

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.